Atlas Trials

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

Clinical trial NCT06211790 · RECRUITING

Trial details

NCT number
NCT06211790
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney CancerRenal Cell CarcinomaRenal Clear Cell Carcinoma
Start date
2024-01-16
Primary completion
2025-12-30
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.